⌘K
Loading ticker…
Aurinia Pharmaceuticals Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Aurinia Pharmaceuticals Inc (AUPH) has a 3-month relative strength percentile of 69 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.1%, relative volume 2.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
69 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
AUPH is in a stage 2 uptrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 8.0% / 17.1%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
AUPH is held by 3 ETFs as of Mar 2026. Top owner: IWM at 0.06% weight, $43M notional. Top 3 carry $60M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IWMiShares Russell 2000 ETF | 0.06% | $43M |
| IWOiShares Russell 2000 Growth ETF | 0.12% | $14M |
| SPDWState Street SPDR Portfolio Developed World ex-US ETF | 0.01% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AUPH Jan avg: 18.25% median: -10.19% win: 25% σ: 60.90% n: 4 2022-04-12 → 2026-05-29 | AUPH Feb avg: -6.54% median: -1.24% win: 50% σ: 11.80% n: 4 2022-04-12 → 2026-05-29 | AUPH Mar avg: 3.47% median: 2.86% win: 75% σ: 13.56% n: 4 2022-04-12 → 2026-05-29 | AUPH Apr avg: -0.63% median: 2.49% win: 80% σ: 7.34% n: 5 2022-04-12 → 2026-05-29 | AUPH May avg: -1.89% median: -0.36% win: 40% σ: 11.78% n: 5 2022-04-12 → 2026-05-29 | AUPH Jun avg: 2.63% median: 6.69% win: 75% σ: 9.11% n: 4 2022-04-12 → 2026-05-29 (current) | AUPH Jul avg: 3.29% median: 6.06% win: 75% σ: 16.13% n: 4 2022-04-12 → 2026-05-29 | AUPH Aug avg: 3.45% median: 2.90% win: 50% σ: 23.48% n: 4 2022-04-12 → 2026-05-29 | AUPH Sep avg: -3.09% median: -2.83% win: 50% σ: 9.86% n: 4 2022-04-12 → 2026-05-29 | AUPH Oct avg: 5.03% median: 3.24% win: 50% σ: 11.04% n: 4 2022-04-12 → 2026-05-29 | AUPH Nov avg: 6.52% median: 20.05% win: 75% σ: 29.04% n: 4 2022-04-12 → 2026-05-29 | AUPH Dec avg: -2.86% median: 0.15% win: 50% σ: 8.87% n: 4 2022-04-12 → 2026-05-29 |